South America Asparaginase Market Forecast to 2028

South America Asparaginase Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Escherichia Coli, Erwinia Chrysanthemi, Pegylated, and Others), Application (Therapeutic, Food Processing, and Others), and End-use Industry (Healthcare and Food Manufacturing)

Report Code : BMIRE00027453 | Region : LAMEA | Industry : Pharmaceuticals | Published Date : 14/Nov/2022

The SAM asparaginase market is expected to grow from US$ 32.29 million in 2022 to US$ 73.24 million by 2028; it is estimated to grow at a CAGR of 14.6% from 2022 to 2028.

New Product Launches and Approvals

The pharmaceutical and food industries are constantly developing at a significant rate due to the rising demand from a large population has increased new product development, product launches, and approvals on a regional level. Additionally, major market players are involved in research and development activities to ensure the innovation and development of efficient products. In recent years there have been various developments, such as product launches and approvals taking place in the market, which are likely to create ample opportunities in the market. For instance, In July 2021, Ligand Pharmaceuticals Incorporated partnered with Jazz Pharmaceuticals Plc to launch Rylaze (asparaginase Erwinia Chrysanthemi (recombinant)-rywn), also known as JZP458. Rylaze is a recombinant erwinia asparaginase used as a component of a multi-agent chemotherapeutic regimen for treating acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL) in adult and pediatric patients 1 month or older who have developed hypersensitivity to E. coli-derived asparaginase. Similarly, in August 2020, Lonza expanded microbial capacity and extended long-term partnership with Servier Pharmaceuticals, Inc. for l-asparaginase API manufacturing. The new facility will provide mid-scale commercial manufacturing to multiple customers and serve the growing needs of Servier, an independent international pharmaceutical company and long-term Lonza partner. Thus, the increase in new product development, launches, and other strategic collaborations among market players are likely to create ample opportunities and drive market growth in the coming years.

Market Overview

The SAM asparaginase market is segmented into Brazil, Argentina, and the Rest of SAM. Brazil dominated the market in 2022. As per World Health Organization report, 11,445 new cases of non-Hodgkin lymphoma and 11,363 new cases of leukemia were reported in Brazil in 2020. There has been development in healthcare facilities and products along with the rising prevalence of leukemia and lymphoma in Brazil. According to National Library of Medicine report, the Brazilian Ministry of Health acquired a new l-asparaginase produced by Beijing SL Pharmaceutical (China) with the trade name of Leuginase in 2017. Moreover, Brazil has the second largest food processing industry in North America and South America, after the US. The country also has the second largest agricultural industry and also exports most of the food items and ingredients to the neighboring countries. Brazil has experienced significant growth in the food process industry, which has further created the demand for asparaginase. For instance, according to Brazilian Food Processors' Association, the Brazil food processing industry generated the revenue of US$ 171 billion in 2021, which is an increase of 16.9% as compared to 2020. Thus, the rising prevalence of leukemia and lymphoma, along with surge in application of asparaginase in the agricultural & food industries in the country, is expected to proliferate the growth of asparaginase market over the forecast period.

SAM Asparaginase Market Revenue and Forecast to 2028 (US$ Million)

SAM Asparaginase Market Segmentation

The SAM asparaginase market is segmented based on type, application, end-use industry, and country.

Based on type, the SAM asparaginase market is segmented into escherichia coli, erwinia chrysanthemi, pegylated, and others. The escherichia coli segment held the largest market share in 2022. Based on application, the SAM asparaginase market is segmented into therapeutic, food processing, and others. The therapeutic segment held the largest market share in 2022. The therapeutic segment is further classified into acute lymphoblastic leukemia, lymphoblastic lymphoma, and others. Based on end-use industry, the SAM asparaginase market is bifurcated into healthcare and food manufacturing. The healthcare segment held the larger market share in 2022. Based on country, the SAM asparaginase market has been categorized into Brazil, Argentina, and rest of SAM. Our regional analysis states that Brazil dominated the market in 2022. Biovendor, LLC; Creative Enzymes; Jazz Pharmaceuticals, Inc.; medac GMBH; Servier Pharmaceuticals LLC; Taj Pharmaceuticals Limited; and United Biotech (P) Limited are the leading companies operating in the SAM asparaginase market.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Asparaginase Market – By Type

1.3.2 SAM Asparaginase Market – By Application

1.3.3 SAM Asparaginase Market – By End-Use Industry

1.3.4 SAM Asparaginase Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SAM Asparaginase Market – Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.3 Experts Opinion

5. SAM Asparaginase Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidences of Leukemia and Increasing Usage Application

5.1.2 Significant Growth of Pharmaceutical and Food Industry

5.2 Market Restraints

5.2.1 Side Effects Associated With Use of Asparaginase

5.3 Market Opportunities

5.3.1 New Product Launches and Approvals

5.4 Future Trends

5.4.1 Increase in R&D Activities and Investment by Market Players

5.5 Impact Analysis

6. Asparaginase Market– SAM Analysis

6.1 SAM Asparaginase Market Revenue Forecasts and Analysis

7. SAM Asparaginase Market Analysis – By Type

7.1 Overview

7.2 By Type: SAM Market Revenue and Forecast Analysis (US$ Million)

7.2.1 Escherichia Coli

7.2.1.1 Overview

7.2.1.2 Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)

7.2.2 Erwinia Chrysanthemi

7.2.2.1 Overview

7.2.2.2 Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)

7.2.3 Pegylated

7.2.3.1 Overview

7.2.3.2 Pegylated Market Revenue and Forecast to 2028 (US$ Million)

7.2.4 Others

7.2.4.1 Overview

7.2.4.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. SAM Asparaginase Market Analysis – By Application

8.1 Overview

8.2 By Application: SAM Market Revenue and Forecast Analysis (US$ Million)

8.2.1 Therapeutic

8.2.1.1 Overview

8.2.1.2 Therapeutic Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.3 Acute Lymphoblastic Leukaemia (ALL)

8.2.1.3.1 Acute lymphoblastic leukemia Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.4 Lymphoblastic Lymphoma (LBL)

8.2.1.4.1 Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.5 Others

8.2.1.5.1 Others Market Revenue and Forecast to 2028 (US$ Million)

8.2.2 Food Processing

8.2.2.1 Overview

8.2.2.2 Food Processing Market Revenue and Forecast to 2028 (US$ Million)

8.2.3 Others

8.2.3.1 Overview

8.2.3.2 Others Market Revenue and Forecast to 2028 (US$ Million)

9. SAM Asparaginase Market Analysis – By End-use Industry

9.1 By End-Use: SAM Market Revenue and Forecast Analysis (US$ Million)

9.1.1 Healthcare

9.1.1.1 Overview

9.1.1.2 Healthcare Market Revenue and Forecast to 2028 (US$ Million)

9.1.2 Food Manufacturing

9.1.2.1 Overview

9.1.2.2 Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

10. SAM Asparaginase Market – Country Analysis

10.1 Overview

10.1.1 SAM: Asparaginase Market, by Country, 2021 & 2028 (%)

10.1.1.1 Brazil: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.1.1 Overview

10.1.1.1.2 Brazil: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.1.3 Brazil: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.1.1.4 Brazil: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.1.1.4.1 Brazil: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.1.1.5 Brazil: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.1.1.2 Argentina: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.2.1 Overview

10.1.1.2.2 Argentina: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.2.3 Argentina: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.1.2.4 Argentina: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.1.2.4.1 Argentina: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.1.2.5 Argentina: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.1.1.3 Rest of SAM: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.3.1 Overview

10.1.1.3.2 Rest of SAM: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.3.3 Rest of SAM: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.1.3.4 Rest of SAM: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.1.3.4.1 Rest of SAM: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.1.3.5 Rest of SAM: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

11. Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Servier Pharmaceuticals LLC

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Biovendor, LLC

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Creative Enzymes

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Taj Pharmaceuticals Limited

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 medac GMBH

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Jazz Pharmaceuticals, Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 United Biotech (P) Limited

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. SAM Asparaginase Market– Revenue and Forecast to 2028 (US$ Mn)

Table 2. Brazil: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3. Brazil: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4. Brazil: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5. Brazil: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6. Argentina: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7. Argentina: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8. Argentina: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9. Argentina: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10. Rest of SAM: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11. Rest of SAM: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12. Rest of SAM: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13. Rest of SAM: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 14. Recent Inorganic Growth Strategies

Table 15. Recent Organic Growth Strategies

Table 16. Glossary of Terms

LIST OF FIGURES.

Figure 1. SAM Asparaginase Market Segmentation

Figure 2. SAM Asparaginase Market Segmentation, by Country

Figure 3. SAM Asparaginase Market Overview

Figure 4. SAM Asparaginase Market, By Type

Figure 5. SAM Asparaginase Market, By Country

Figure 7. SAM: PEST Analysis

Figure 8. Experts Opinion

Figure 9. SAM Asparaginase Market Impact Analysis of Drivers and Restraints

Figure 10. SAM Asparaginase Market – Revenue Forecasts and Analysis

Figure 11. By Type: SAM Market Analysis and Forecast 2021 and 2028 (%)

Figure 12. SAM Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. SAM Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. SAM Pegylated Market Revenue and Forecast to 2028 (US$ Million)

Figure 15. SAM Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 16. By Application: SAM Market Analysis and Forecast 2021 and 2028 (%)

Figure 17. SAM Therapeutic Market Revenue and Forecast to 2028 (US$ Million)

Figure 18. SAM Acute Lymphoblastic Leukemia Market Revenue and Forecast to 2028 (US$ Million)

Figure 19. SAM Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)

Figure 20. SAM Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 21. SAM Food Processing Market Revenue and Forecast to 2028 (US$ Million)

Figure 22. SAM Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 23. By End-Use: SAM Market Analysis and Forecast 2021 and 2028 (%)

Figure 24. SAM Healthcare Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. SAM Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

Figure 26. SAM: Asparaginase Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 27. SAM: Asparaginase Market, by Country, 2021 & 2028 (%)

Figure 28. Brazil: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 29. Argentina: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 30. Rest of SAM: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

The List of Companies - South America Asparaginase Market

● Biovendor, LLC

● Creative Enzymes

● Jazz Pharmaceuticals, Inc.

● medac GMBH

● Servier Pharmaceuticals LLC

● Taj Pharmaceuticals Limited

● United Biotech (P) Limited

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM asparaginase market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the SAM asparaginase market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the asparaginase market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Back to Industry Report

Pricing
	$3,000.00	Single User Price
	$4,000.00	Site Price
	$5,000.00	Enterprise Price
Buy Now

South America Asparaginase Market Forecast to 2028 – COVID

Have Additional Questions?